EUVIMEDOpdag EUVIMED
Open access

Miniprotein engineering for inhibition of PD ‐1/ PD ‐ L1 interaction

Agnieszka Ciesiołkiewicz, Juan Lizandra Perez, Lukasz Skalniak, Paweł Noceń, Łukasz Berlicki iD

Protein Science · 2024

DOI: 10.1002/pro.5106 ↗

At a glance

Journal article in Protein Science, 2024. Written by Agnieszka Ciesiołkiewicz and 4 co-authors. Institution: Department of Bioorganic Chemistry, Wrocław University of Science and Technology, Wrocław, Poland. Major MEDLINE topics: Programmed Cell Death 1 Receptor, B7-H1 Antigen, Protein Engineering. Cited 3 times so far (Crossref); 56 references. The full text is freely available in PubMed Central. Funded by: National Science Centre, Poland, Narodowe Centrum Nauki.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Miniproteins constitute an excellent basis for the development of structurally demanding functional molecules. The engrailed homeodomain, a three‐helix‐containing miniprotein, was applied as a scaffold for constructing programmed cell death protein 1/programmed death‐ligand 1 (PD‐1/PD‐L1) interaction inhibitors. PD‐L1 binders were initially designed using the computer‐aided approach and subsequently optimized iteratively. The conformational stability was assessed for each obtained miniprotein using circular dichroism spectroscopy, indicating that numerous mutations could be introduced. The formation of a sizable hydrophobic surface at the inhibitor that fits the molecular target imposed the necessity for the incorporation of additional charged amino acid residues to retain its appropriate solubility. Finally, the miniprotein effectively binding to PD‐L1 ( K D = 51.4 nM) that inhibits PD‐1/PD‐L1 interaction in cell‐based studies with EC 50 = 3.9 μM, was discovered.

Subjects

MeSH terms (MEDLINE)

Programmed Cell Death 1 ReceptorB7-H1 AntigenProtein EngineeringHumansProtein BindingModels, MolecularHomeodomain Proteins

Author keywords

cancercircular dichroismimmunotherapypeptidesprotein–protein interactions

Substances

Programmed Cell Death 1 ReceptorB7-H1 AntigenCD274 protein, humanPDCD1 protein, humanHomeodomain Proteins

Authors and institutions

  • Department of Bioorganic Chemistry, Wrocław University of Science and Technology, Wrocław, Poland.
  • Faculty of Chemistry, Jagiellonian University, Kraków, Poland.

ORCID profiles: Łukasz Berlicki

Funding

  • National Science Centre, Poland
  • Narodowe Centrum Nauki

Cite

APA

Ciesiołkiewicz, A., Lizandra Perez, J., Skalniak, L., Noceń, P., & Berlicki, Ł. (2024). Miniprotein engineering for inhibition of PD ‐1/ PD ‐ L1 interaction. Protein Science. https://doi.org/10.1002/pro.5106

Vancouver

Ciesiołkiewicz A, Lizandra Perez J, Skalniak L, Noceń P, Berlicki Ł. Miniprotein engineering for inhibition of PD ‐1/ PD ‐ L1 interaction. Protein Science. 2024. doi:10.1002/pro.5106

BibTeX
@article{Ciesiokiewicz2024,
  author = {Ciesiołkiewicz, Agnieszka and Lizandra Perez, Juan and Skalniak, Lukasz and Noceń, Paweł and Berlicki, Łukasz},
  title = {Miniprotein engineering for inhibition of PD ‐1/ PD ‐ L1 interaction},
  journal = {Protein Science},
  year = {2024},
  doi = {10.1002/pro.5106}
}
Start for free →